Open-House-Biologika Discount Agreements 2025-36 - Natalizumab (Dosage form for subcutaneous injection)
Open-House-Biologika-Rabattverträge 2025-36 - Natalizumab (Darreichungsform zur subkutanen Injektion)
Germany
Contract
BuyerTechniker Krankenkasse
TypeSupplies
Estimated valuevalue not published
Published23 November 2025
CategoryMedical equipment & pharma · CPV 33000000
Who has won here before
| Company | Awards | Period |
|---|---|---|
| Computacenter AG & Co. oHG | 76 | 2006–2026 |
| Siehe im Feld "Allgemeine Informationen" | 55 | 2023–2026 |
| Hexal AG · Holzkirchen | 43 | 2011–2026 |
| Aliud Pharma GmbH · Laichingen | 38 | 2011–2025 |
| Aristo Pharma GmbH · Berlin | 33 | 2012–2026 |
From 13.7M documented awards · regular winners know this buyer's requirements — that is your competition.
How often this buyer tenders this
201986
202036
202122
202229
202354
2024263
20251
2025550
2026275
Who knows the rhythm prepares instead of reacting.
530
days until the deadline — Monday 31 January at 21:58
How to bid
Read the full notice — Original + documents
Goes directly to this tender on Vergabemarktplatz (cosinex). The full specification and all annexes are there.
Tenders like this, every morning at 7:30 in your inbox.
Start free →